| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# | Aug 28, 2024 | |
| SC 13D/A | Report | AMENDMENT NO. 4 | May 16, 2023 | |
| SC 13D/A | Report | AMENDMENT NO. 3 | Dec 27, 2022 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# | Sep 7, 2022 | |
| SC 13D/A | Report | AMENDMENT NO. 2 | Aug 12, 2022 | |
| SC 13D/A | Report | SC 13D/A | Aug 11, 2022 | |
| SC 13D/A | Report | SC 13D/A | Oct 5, 2020 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# | Aug 3, 2020 | |
| SC 13D/A | Report | VERONA PHARMA PLC AMENDMENT NO. 1 | Jul 31, 2020 | |
| SC 13D/A | Report | AMENDMENT NO. 1 TO SCHEDULE 13D | Jul 24, 2020 | |
| SC 13D | Report | SC 13D | Apr 2, 2019 | |
| SC 13D/A | Report | AMENDMENT NO. 1 | Jan 26, 2018 | |
| SC 13D | Report | VERONA PHARMA PLC -- SCHEDULE 13D | May 9, 2017 | |
| SC 13D | Report | VERONA PHARMA PLC SC 13D | May 8, 2017 | |
| SC 13D | Report | SCHEDULE 13D | May 8, 2017 |